Global Humira Market Report (2026–2036)
Market Overview
The global Humira (adalimumab) market is projected to grow steadily during 2026–2036, driven by rising prevalence of autoimmune diseases, increasing demand for biologics, and expansion of biosimilars. Humira, a monoclonal antibody targeting TNF-α, is widely used in the treatment of rheumatoid arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, psoriasis, and other autoimmune conditions. While AbbVie remains the primary innovator, the market landscape is evolving with the entry of biosimilars and competitive biologics.
Key Players
In addition to AbbVie, Abbott, Knoll, Pfizer, Johnson & Johnson, and CAT, the following companies are also significant participants in the global Humira market and biosimilars segment:
- Amgen Inc. (US)
- Samsung Bioepis (South Korea)
- Biogen Inc. (US)
- Novartis AG (Sandoz, Switzerland)
- Fresenius Kabi (Germany)
- Celltrion Healthcare (South Korea)
- Mylan/Viatris (US)
- Boehringer Ingelheim (Germany)
- Coherus BioSciences (US)
- Orion Pharma (Finland)
These players compete on innovation, biosimilar development, regulatory approvals, pricing strategies, and global distribution networks.
Segments Analysis
By Product Type
- Type I (Innovator Biologics) – Original Humira formulations by AbbVie.
- Type II (Biosimilars) – Adalimumab biosimilars launched by multiple companies post-patent expiry.
By Application
- Autoimmune Diseases – Broad category including Crohn’s disease, ulcerative colitis, and psoriasis.
- Rheumatoid Arthritis – Largest segment; Humira remains a frontline biologic therapy.
- Spondylitis – Includes ankylosing spondylitis and related inflammatory conditions.
- Others – Juvenile idiopathic arthritis, hidradenitis suppurativa, and uveitis.
Regional Analysis
- North America – Largest market; US dominates due to high biologics adoption and AbbVie’s strong presence.
- Europe – Significant biosimilar penetration; Germany, UK, and France lead adoption.
- Asia-Pacific – Fastest-growing region; China, India, and Japan drive growth with rising autoimmune disease prevalence and biosimilar launches.
- South America – Brazil and Argentina show increasing adoption in urban healthcare systems.
- Middle East & Africa – Emerging demand in Saudi Arabia, Turkey, and South Africa, supported by expanding biologics access programs.
Porter’s Five Forces
- Threat of New Entrants – Moderate; biosimilar entry requires regulatory approvals and manufacturing expertise.
- Bargaining Power of Suppliers – Moderate; biologics manufacturing depends on specialized raw materials and bioprocessing.
- Bargaining Power of Buyers – High; healthcare systems and insurers demand cost-effective biosimilars.
- Threat of Substitutes – Moderate; alternative biologics and JAK inhibitors compete with Humira.
- Industry Rivalry – High; intense competition between AbbVie and biosimilar manufacturers.
SWOT Analysis
Strengths
- Proven efficacy across multiple autoimmune conditions.
- Strong brand recognition and established global presence.
- Wide range of indications approved worldwide.
Weaknesses
- High treatment costs compared to biosimilars.
- Dependence on patent protection for market exclusivity.
- Risk of adverse effects and immunogenicity.
Opportunities
- Rising prevalence of autoimmune diseases globally.
- Expansion of biosimilars in emerging markets.
- Growth in personalized medicine and targeted biologics.
Threats
- Intense competition from biosimilars and alternative biologics.
- Price sensitivity in cost-conscious healthcare systems.
- Stringent regulatory requirements across regions.
Trend Analysis
- Increasing adoption of adalimumab biosimilars post-patent expiry.
- Rising popularity of subcutaneous self-injection devices for patient convenience.
- Growth in value-based healthcare models driving biosimilar uptake.
- Expansion of digital health platforms for biologic monitoring.
- Development of next-generation TNF inhibitors and JAK inhibitors.
Drivers & Challenges
Drivers
- Rising prevalence of autoimmune diseases worldwide.
- Expanding demand for biologics and biosimilars.
- Technological advancements in biologic manufacturing.
Challenges
- High costs of innovator biologics.
- Regulatory hurdles in biosimilar approvals.
- Competition from alternative therapies (JAK inhibitors, IL-17/IL-23 inhibitors).
Value Chain Analysis
- Raw Material Suppliers – Bioprocessing inputs, cell lines, and specialized reagents.
- Manufacturers – Innovator biologics (AbbVie) and biosimilar producers.
- Distributors/Wholesalers – Hospital supply chains, pharmacies, and specialty distributors.
- Healthcare Providers – Hospitals, clinics, and rheumatology centers.
- Patients – End users benefiting from improved autoimmune disease management.
Quick Recommendations for Stakeholders
- Manufacturers: Invest in biosimilar development and patient-friendly delivery systems.
- Distributors: Strengthen partnerships with hospitals and specialty pharmacies.
- Investors: Focus on companies innovating in biosimilars and next-generation biologics.
- Policy Makers: Support reimbursement policies and affordable access to biologics and biosimilars.
- Healthcare Providers: Integrate biosimilars into treatment protocols for cost-effective patient care.
Table of Contents
Global Humira Sales Market Report 2018
1 Humira Market Overview
1.1 Product Overview and Scope of Humira
1.2 Classification of Humira by Product Category
1.2.1 Global Humira Market Size (Sales) Comparison by Type
1.2.2 Global Humira Market Size (Sales) Market Share by Type (Product Category) in
1.2.3 Type I
1.2.4 Type II
1.3 Global Humira Market by Application/End Users
1.3.1 Global Humira Sales (Volume) and Market Share Comparison by Application
1.3.1 Autoimmune Diseases
1.3.2 Rheumatoid Arthritis
1.3.3 Spondylitis
1.4 Global Humira Market by Region
1.4.1 Global Humira Market Size (Value) Comparison by Region
1.4.2 United States Humira Status and Prospect
1.4.3 Europe Humira Status and Prospect
1.4.4 China Humira Status and Prospect
1.4.5 Japan Humira Status and Prospect
1.4.6 Southeast Asia Humira Status and Prospect
1.4.7 India Humira Status and Prospect
1.5 Global Market Size (Value and Volume) of Humira
1.5.1 Global Humira Sales and Growth Rate
1.5.2 Global Humira Revenue and Growth Rate
2 Global Humira Competition by Players/Suppliers, Type and Application
2.1 Global Humira Market Competition by Players/Suppliers
2.1.1 Global Humira Sales and Market Share of Key Players/Suppliers ()
2.1.2 Global Humira Revenue and Share by Players/Suppliers ()
2.2 Global Humira (Volume and Value) by Type
2.2.1 Global Humira Sales and Market Share by Type ()
2.2.2 Global Humira Revenue and Market Share by Type ()
2.3 Global Humira (Volume and Value) by Region
2.3.1 Global Humira Sales and Market Share by Region ()
2.3.2 Global Humira Revenue and Market Share by Region ()
2.4 Global Humira (Volume) by Application
3 United States Humira (Volume, Value and Sales Price)
3.1 United States Humira Sales and Value ()
3.1.1 United States Humira Sales and Growth Rate ()
3.1.2 United States Humira Revenue and Growth Rate ()
3.1.3 United States Humira Sales Price Trend ()
3.2 United States Humira Sales Volume and Market Share by Players ()
3.3 United States Humira Sales Volume and Market Share by Type ()
3.4 United States Humira Sales Volume and Market Share by Application ()
4 Europe Humira (Volume, Value and Sales Price)
4.1 Europe Humira Sales and Value ()
4.1.1 Europe Humira Sales and Growth Rate ()
4.1.2 Europe Humira Revenue and Growth Rate ()
4.1.3 Europe Humira Sales Price Trend ()
4.2 Europe Humira Sales Volume and Market Share by Players ()
4.3 Europe Humira Sales Volume and Market Share by Type ()
4.4 Europe Humira Sales Volume and Market Share by Application ()
5 China Humira (Volume, Value and Sales Price)
5.1 China Humira Sales and Value ()
5.1.1 China Humira Sales and Growth Rate ()
5.1.2 China Humira Revenue and Growth Rate ()
5.1.3 China Humira Sales Price Trend ()
5.2 China Humira Sales Volume and Market Share by Players ()
5.3 China Humira Sales Volume and Market Share by Type ()
5.4 China Humira Sales Volume and Market Share by Application ()
6 Japan Humira (Volume, Value and Sales Price)
6.1 Japan Humira Sales and Value ()
6.1.1 Japan Humira Sales and Growth Rate ()
6.1.2 Japan Humira Revenue and Growth Rate ()
6.1.3 Japan Humira Sales Price Trend ()
6.2 Japan Humira Sales Volume and Market Share by Players ()
6.3 Japan Humira Sales Volume and Market Share by Type ()
6.4 Japan Humira Sales Volume and Market Share by Application ()
7 Southeast Asia Humira (Volume, Value and Sales Price)
7.1 Southeast Asia Humira Sales and Value ()
7.1.1 Southeast Asia Humira Sales and Growth Rate ()
7.1.2 Southeast Asia Humira Revenue and Growth Rate ()
7.1.3 Southeast Asia Humira Sales Price Trend ()
7.2 Southeast Asia Humira Sales Volume and Market Share by Players ()
7.3 Southeast Asia Humira Sales Volume and Market Share by Type ()
7.4 Southeast Asia Humira Sales Volume and Market Share by Application ()
8 India Humira (Volume, Value and Sales Price)
8.1 India Humira Sales and Value ()
8.1.1 India Humira Sales and Growth Rate ()
8.1.2 India Humira Revenue and Growth Rate ()
8.1.3 India Humira Sales Price Trend ()
8.2 India Humira Sales Volume and Market Share by Players ()
8.3 India Humira Sales Volume and Market Share by Type ()
8.4 India Humira Sales Volume and Market Share by Application ()
9 Global Humira Players/Suppliers Profiles and Sales Data
9.1 AbbVie
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Humira Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 AbbVie Humira Sales, Revenue, Price and Gross Margin ()
9.1.4 Main Business/Business Overview
9.2 Abbott
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Humira Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Abbott Humira Sales, Revenue, Price and Gross Margin ()
9.2.4 Main Business/Business Overview
9.3 Knoll
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Humira Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Knoll Humira Sales, Revenue, Price and Gross Margin ()
9.3.4 Main Business/Business Overview
9.4 Pfizer
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Humira Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Pfizer Humira Sales, Revenue, Price and Gross Margin ()
9.4.4 Main Business/Business Overview
9.5 Johnson & Johnson
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Humira Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Johnson & Johnson Humira Sales, Revenue, Price and Gross Margin ()
9.5.4 Main Business/Business Overview
9.6 CAT
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Humira Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 CAT Humira Sales, Revenue, Price and Gross Margin ()
9.6.4 Main Business/Business Overview
...
10 Humira Maufacturing Cost Analysis
10.1 Humira Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Humira
10.3 Manufacturing Process Analysis of Humira
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Humira Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Humira Major Manufacturers in
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Humira Market Forecast (2018-2025)
14.1 Global Humira Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Humira Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Humira Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Humira Price and Trend Forecast (2018-2025)
14.2 Global Humira Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Humira Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Humira Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Humira Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Humira Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Humira Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Humira Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Humira Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Humira Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Humira Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Humira Sales Forecast by Type (2018-2025)
14.3.2 Global Humira Revenue Forecast by Type (2018-2025)
14.3.3 Global Humira Price Forecast by Type (2018-2025)
14.4 Global Humira Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Humira
Figure Global Humira Sales Volume Comparison (K Units) by Type
Figure Global Humira Sales Volume Market Share by Type (Product Category) in
Figure Type I Product Picture
Figure Type II Product Picture
Figure Global Humira Sales Comparison (K Units) by Application
Figure Global Sales Market Share of Humira by Application in
Figure Autoimmune Diseases Examples
Table Key Downstream Customer in Autoimmune Diseases
Figure Rheumatoid Arthritis Examples
Table Key Downstream Customer in Rheumatoid Arthritis
Figure Spondylitis Examples
Table Key Downstream Customer in Spondylitis
Figure Global Humira Market Size (Million USD) by Regions
Figure United States Humira Revenue (Million USD) and Growth Rate
Figure Europe Humira Revenue (Million USD) and Growth Rate
Figure China Humira Revenue (Million USD) and Growth Rate
Figure Japan Humira Revenue (Million USD) and Growth Rate
Figure Southeast Asia Humira Revenue (Million USD) and Growth Rate
Figure India Humira Revenue (Million USD) and Growth Rate
Figure Global Humira Sales Volume (K Units) and Growth Rate
Figure Global Humira Revenue (Million USD) and Growth Rate
Figure Global Market Major Players Humira Sales Volume (K Units) ()
Table Global Humira Sales (K Units) of Key Players/Suppliers ()
Table Global Humira Sales Share by Players/Suppliers ()
Figure Humira Sales Share by Players/Suppliers
Figure Humira Sales Share by Players/Suppliers
Figure Global Humira Revenue (Million USD) by Players/Suppliers ()
Table Global Humira Revenue (Million USD) by Players/Suppliers ()
Table Global Humira Revenue Share by Players/Suppliers ()
Table Global Humira Revenue Share by Players
Table Global Humira Revenue Share by Players
Table Global Humira Sales (K Units) and Market Share by Type ()
Table Global Humira Sales Share (K Units) by Type ()
Figure Sales Market Share of Humira by Type ()
Figure Global Humira Sales Growth Rate by Type ()
Table Global Humira Revenue (Million USD) and Market Share by Type ()
Table Global Humira Revenue Share by Type ()
Figure Revenue Market Share of Humira by Type ()
Figure Global Humira Revenue Growth Rate by Type ()
Table Global Humira Sales Volume (K Units) and Market Share by Region ()
Table Global Humira Sales Share by Region ()
Figure Sales Market Share of Humira by Region ()
Figure Global Humira Sales Growth Rate by Region in
Table Global Humira Revenue (Million USD) and Market Share by Region ()
Table Global Humira Revenue Share (%) by Region ()
Figure Revenue Market Share of Humira by Region ()
Figure Global Humira Revenue Growth Rate by Region in
Table Global Humira Revenue (Million USD) and Market Share by Region ()
Table Global Humira Revenue Share (%) by Region ()
Figure Revenue Market Share of Humira by Region ()
Figure Global Humira Revenue Market Share by Region in
Table Global Humira Sales Volume (K Units) and Market Share by Application ()
Table Global Humira Sales Share (%) by Application ()
Figure Sales Market Share of Humira by Application ()
Figure Global Humira Sales Market Share by Application ()
Figure United States Humira Sales (K Units) and Growth Rate ()
Figure United States Humira Revenue (Million USD) and Growth Rate ()
Figure United States Humira Sales Price (USD/Unit) Trend ()
Table United States Humira Sales Volume (K Units) by Players ()
Table United States Humira Sales Volume Market Share by Players ()
Figure United States Humira Sales Volume Market Share by Players in
Table United States Humira Sales Volume (K Units) by Type ()
Table United States Humira Sales Volume Market Share by Type ()
Figure United States Humira Sales Volume Market Share by Type in
Table United States Humira Sales Volume (K Units) by Application ()
Table United States Humira Sales Volume Market Share by Application ()
Figure United States Humira Sales Volume Market Share by Application in
Figure Europe Humira Sales (K Units) and Growth Rate ()
Figure Europe Humira Revenue (Million USD) and Growth Rate ()
Figure Europe Humira Sales Price (USD/Unit) Trend ()
Table Europe Humira Sales Volume (K Units) by Players ()
Table Europe Humira Sales Volume Market Share by Players ()
Figure Europe Humira Sales Volume Market Share by Players in
Table Europe Humira Sales Volume (K Units) by Type ()
Table Europe Humira Sales Volume Market Share by Type ()
Figure Europe Humira Sales Volume Market Share by Type in
Table Europe Humira Sales Volume (K Units) by Application ()
Table Europe Humira Sales Volume Market Share by Application ()
Figure Europe Humira Sales Volume Market Share by Application in
Figure China Humira Sales (K Units) and Growth Rate ()
Figure China Humira Revenue (Million USD) and Growth Rate ()
Figure China Humira Sales Price (USD/Unit) Trend ()
Table China Humira Sales Volume (K Units) by Players ()
Table China Humira Sales Volume Market Share by Players ()
Figure China Humira Sales Volume Market Share by Players in
Table China Humira Sales Volume (K Units) by Type ()
Table China Humira Sales Volume Market Share by Type ()
Figure China Humira Sales Volume Market Share by Type in
Table China Humira Sales Volume (K Units) by Application ()
Table China Humira Sales Volume Market Share by Application ()
Figure China Humira Sales Volume Market Share by Application in
Figure Japan Humira Sales (K Units) and Growth Rate ()
Figure Japan Humira Revenue (Million USD) and Growth Rate ()
Figure Japan Humira Sales Price (USD/Unit) Trend ()
Table Japan Humira Sales Volume (K Units) by Players ()
Table Japan Humira Sales Volume Market Share by Players ()
Figure Japan Humira Sales Volume Market Share by Players in
Table Japan Humira Sales Volume (K Units) by Type ()
Table Japan Humira Sales Volume Market Share by Type ()
Figure Japan Humira Sales Volume Market Share by Type in
Table Japan Humira Sales Volume (K Units) by Application ()
Table Japan Humira Sales Volume Market Share by Application ()
Figure Japan Humira Sales Volume Market Share by Application in
Figure Southeast Asia Humira Sales (K Units) and Growth Rate ()
Figure Southeast Asia Humira Revenue (Million USD) and Growth Rate ()
Figure Southeast Asia Humira Sales Price (USD/Unit) Trend ()
Table Southeast Asia Humira Sales Volume (K Units) by Players ()
Table Southeast Asia Humira Sales Volume Market Share by Players ()
Figure Southeast Asia Humira Sales Volume Market Share by Players in
Table Southeast Asia Humira Sales Volume (K Units) by Type ()
Table Southeast Asia Humira Sales Volume Market Share by Type ()
Figure Southeast Asia Humira Sales Volume Market Share by Type in
Table Southeast Asia Humira Sales Volume (K Units) by Application ()
Table Southeast Asia Humira Sales Volume Market Share by Application ()
Figure Southeast Asia Humira Sales Volume Market Share by Application in
Figure India Humira Sales (K Units) and Growth Rate ()
Figure India Humira Revenue (Million USD) and Growth Rate ()
Figure India Humira Sales Price (USD/Unit) Trend ()
Table India Humira Sales Volume (K Units) by Players ()
Table India Humira Sales Volume Market Share by Players ()
Figure India Humira Sales Volume Market Share by Players in
Table India Humira Sales Volume (K Units) by Type ()
Table India Humira Sales Volume Market Share by Type ()
Figure India Humira Sales Volume Market Share by Type in
Table India Humira Sales Volume (K Units) by Application ()
Table India Humira Sales Volume Market Share by Application ()
Figure India Humira Sales Volume Market Share by Application in
Table AbbVie Basic Information List
Table AbbVie Humira Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure AbbVie Humira Sales Growth Rate ()
Figure AbbVie Humira Sales Global Market Share ()
Figure AbbVie Humira Revenue Global Market Share ()
Table Abbott Basic Information List
Table Abbott Humira Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Abbott Humira Sales Growth Rate ()
Figure Abbott Humira Sales Global Market Share ()
Figure Abbott Humira Revenue Global Market Share ()
Table Knoll Basic Information List
Table Knoll Humira Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Knoll Humira Sales Growth Rate ()
Figure Knoll Humira Sales Global Market Share (
Figure Knoll Humira Revenue Global Market Share ()
Table Pfizer Basic Information List
Table Pfizer Humira Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Pfizer Humira Sales Growth Rate ()
Figure Pfizer Humira Sales Global Market Share ()
Figure Pfizer Humira Revenue Global Market Share ()
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Humira Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure Johnson & Johnson Humira Sales Growth Rate ()
Figure Johnson & Johnson Humira Sales Global Market Share ()
Figure Johnson & Johnson Humira Revenue Global Market Share ()
Table CAT Basic Information List
Table CAT Humira Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin ()
Figure CAT Humira Sales Growth Rate ()
Figure CAT Humira Sales Global Market Share (
Figure CAT Humira Revenue Global Market Share ()
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Humira
Figure Manufacturing Process Analysis of Humira
Figure Humira Industrial Chain Analysis
Table Raw Materials Sources of Humira Major Players in
Table Major Buyers of Humira
Table Distributors/Traders List
Figure Global Humira Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Humira Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Humira Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Humira Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Humira Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Humira Sales Volume Market Share Forecast by Regions in 2025
Table Global Humira Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Humira Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Humira Revenue Market Share Forecast by Regions in 2025
Figure United States Humira Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Humira Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Humira Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Humira Revenue and Growth Rate Forecast (2018-2025)
Figure China Humira Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Humira Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Humira Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Humira Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Humira Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Humira Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Humira Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Humira Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Humira Sales (K Units) Forecast by Type (2018-2025)
Figure Global Humira Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Humira Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Humira Revenue Market Share Forecast by Type (2018-2025)
Table Global Humira Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Humira Sales (K Units) Forecast by Application (2018-2025)
Figure Global Humira Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Key Players
In addition to AbbVie, Abbott, Knoll, Pfizer, Johnson & Johnson, and CAT, the following companies are also significant participants in the global Humira market and biosimilars segment:
- Amgen Inc. (US)
- Samsung Bioepis (South Korea)
- Biogen Inc. (US)
- Novartis AG (Sandoz, Switzerland)
- Fresenius Kabi (Germany)
- Celltrion Healthcare (South Korea)
- Mylan/Viatris (US)
- Boehringer Ingelheim (Germany)
- Coherus BioSciences (US)
- Orion Pharma (Finland)
These players compete on innovation, biosimilar development, regulatory approvals, pricing strategies, and global distribution networks.
Segments Analysis
By Product Type
- Type I (Innovator Biologics) – Original Humira formulations by AbbVie.
- Type II (Biosimilars) – Adalimumab biosimilars launched by multiple companies post-patent expiry.
By Application
- Autoimmune Diseases – Broad category including Crohn’s disease, ulcerative colitis, and psoriasis.
- Rheumatoid Arthritis – Largest segment; Humira remains a frontline biologic therapy.
- Spondylitis – Includes ankylosing spondylitis and related inflammatory conditions.
- Others – Juvenile idiopathic arthritis, hidradenitis suppurativa, and uveitis.
Regional Analysis
- North America – Largest market; US dominates due to high biologics adoption and AbbVie’s strong presence.
- Europe – Significant biosimilar penetration; Germany, UK, and France lead adoption.
- Asia-Pacific – Fastest-growing region; China, India, and Japan drive growth with rising autoimmune disease prevalence and biosimilar launches.
- South America – Brazil and Argentina show increasing adoption in urban healthcare systems.
- Middle East & Africa – Emerging demand in Saudi Arabia, Turkey, and South Africa, supported by expanding biologics access programs.
